EdgarLookup

Theriva Biologics, Inc.

TOVX NYSE CIK: 0000894158 Pharmaceutical Preparations Inc. in NV
View on SEC.gov →
Overview All Filings Annual Quarterly Insiders

Recent Filings

All 1,001 filings →
Form Description Date
8-K FORM 8-K Mar 23, 2026
DEF 14A DEF 14A Mar 16, 2026
10-K 10-K Mar 12, 2026
8-K FORM 8-K Mar 12, 2026
PRE 14A PRE 14A Mar 4, 2026
8-K FORM 8-K Feb 18, 2026
8-K FORM 8-K Feb 12, 2026
8-K FORM 8-K Jan 12, 2026
4 OWNERSHIP DOCUMENT Jan 6, 2026
4 OWNERSHIP DOCUMENT Jan 6, 2026

Insider Transactions

View all →
Insider Title Type Shares Owns After Date
SHALLCROSS STEVEN A CEO and CFO Purchase 14,000 @ $0.69 250,000 Jun 7, 2023
SHALLCROSS STEVEN A CEO and CFO Purchase 26,000 @ $0.63 236,000 Jun 6, 2023
SHALLCROSS STEVEN A CEO and CFO Purchase 25,000 @ $1.04 210,000 Feb 10, 2023
SHALLCROSS STEVEN A CEO and CFO Purchase 25,000 @ $0.94 185,000 Feb 2, 2023
SHALLCROSS STEVEN A CEO and CFO Purchase 25,000 @ $0.87 160,000 Jan 25, 2023
SHALLCROSS STEVEN A CEO and CFO Purchase 25,000 @ $0.75 135,000 Jan 20, 2023
SHALLCROSS STEVEN A CEO and CFO Purchase 100,000 @ $0.44 110,000 Dec 29, 2022
SHALLCROSS STEVEN A CEO and CFO Purchase 50,000 @ $0.49 100,000 May 10, 2021
SHALLCROSS STEVEN A CEO and CFO Purchase 50,000 @ $0.42 50,000 Aug 23, 2019
INTREXON CORP — Sale 69,161 @ $0.65 165,332 Apr 1, 2019